About
We conduct personalized diagnoses using complementary platforms such as Multiplex Blot, POCT, and m-Health. These platforms have been commercialized based on the convergence of bio, nano, and IT technologies. Over the past 10 years, our goal has been to enhance the mobile care system, enabling disease prediction and prevention, diagnosis, customized prescription, and post-treatment monitoring. Our vision is to become a global leader in in vitro diagnostic total platforms, providing accessible solutions for everyone.
Technologies
NginxMobile FriendlyDeelAI
Keywords
allergyfemtechautomationdiagnosticdiagnosispoctmedical equipment manufacturingbiotechnologyserum-free antibody productionmedical devicesdiagnostic reagentfluorescence detectiontrf (time-resolved fluorescence)ige detectionlow power micro analysismobile healthservicesallergen-specific iggmultiplex testingcosmetics diagnosticsallergy testingbio/nano platformfluorescence particle photo-bleachingdigital test technologypoct analyzermultiplex immunoassayfluorescence analysishealth supplementsnanoparticle-based diagnosticsserum-free culture
Company Information
- Employees150
- Founded2011
- Annual Revenue$6844000
Location
Daejeon, Daejeon, South Korea
